Evidence map›Paper›PMID 29663291›Full record

ReviewDrugs2018

Apatinib: A Review in Advanced Gastric Cancer and Other Advanced Cancers.

Lesley J Scott

Erratum issued Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Drugs, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT04642664 (Apatinib Plus Camrelizumab in Patients With Previously Treated Advanced Biliary Tract Cancer), which is not on this map. Cited by 147 papers, 12 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
147citing papers in PubMed, 12 pooled it
15.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04642664 phase2completednot on this map

Apatinib Plus Camrelizumab in Patients With Previously Treated Advanced Biliary Tract Cancer (ACABC): A Prospective Clinical Study

TypeinterventionalSponsorPeking Union Medical College HospitalRan2018 to 2021Enrolled22ConditionsBiliary Tract Cancer, Cholangiocarcinoma, Biomarker, Hepatobiliary NeoplasmArmsApatinib plus Camrelizumab
3 · Its place in the literature

Who cites it

147 citing papers in PubMed, 12 syntheses or guidelines pooled it, 228 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Health-related quality of life associated with trifluridine/tipiracil in heavily pretreated metastatic gastric cancer: results from TAGS.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2020
    Trial
  20. Trial

87 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Lesley J ScottSpringer, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand. demail@springer.com.
Springer Nature (New Zealand) · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Apatinib [Aitan

Indexed as

Antineoplastic AgentsHumansNeoplasmsProtein Kinase InhibitorsPyridinesStomach NeoplasmsTreatment OutcomeVascular Endothelial Growth Factor Receptor-2Antineoplastic AgentsapatinibProtein Kinase InhibitorsPyridinesVascular Endothelial Growth Factor Receptor-2

Identifiers

PMID29663291
OpenAlexW2802168390

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.